|
Market Closed -
NSE India S.E.
07:05:09 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 722.90 INR | -2.91% |
|
+0.99% | +27.96% |
| 07-23 | Solara Active Pharma Sciences Limited, Q1 2027 Earnings Call, Jul 23, 2026 | |
| 07-23 | Solara Active Pharma Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 34.88B 364M 320M 300M 275M 513M 517M 3.61B 1.4B 17.78B 1.37B 1.34B 57.65B | P/E 2025 |
3,792x | P/E 2026 | -253x |
|---|---|---|---|---|---|
| Enterprise Value | 41.67B 435M 382M 359M 328M 613M 618M 4.31B 1.67B 21.24B 1.63B 1.6B 68.88B | EV / Sales 2025 |
2.54x | EV / Sales 2026 | 1.99x |
| Free-Float |
47.76% | Yield 2025 * |
-
| Yield 2026 | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SOLARA | Delayed | |
Bombay S.E.
| SOLARA | Delayed |
Last Transcript: Solara Active Pharma Sciences Limited
| 1 day | -2.91% | ||
| 1 week | +0.99% | ||
| Current month | +14.27% | ||
| 1 month | +17.18% | ||
| 3 months | +23.23% | ||
| 6 months | +60.57% | ||
| Current year | +27.96% |
| 1 week | 715 |  | 765 |
| 1 month | 601.2 | | 774 |
| Current year | 422 | | 774 |
| 1 year | 422 | | 774 |
| 3 years | 286 | | 882.8 |
| 5 years | 286 | | 1,710 |
| 10 years | 134.5 | | 1,859.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandeep Rao
CEO | Chief Executive Officer | - | 2025-02-20 |
Sarat Kumar
DFI | Director of Finance/CFO | - | 2025-02-20 |
Pooja Jaya Kumar
CMP | Compliance Officer | - | 2025-05-14 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2018-04-10 | |
| Director/Board Member | 58 | 2018-04-10 | |
| Director/Board Member | 75 | 2023-11-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/14/25 | Buy | Director | 1,000 | 0.0021% | ||
| 3/6/25 | Pronomz Ventures LLP
| Buy | Company | 13,600 | 0.0283% | |
| 3/4/25 | Pronomz Ventures LLP
| Buy | Company | 216,361 | 0.4503% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.91% | +0.99% | +9.45% | +106.37% | 376M | |
| -1.91% | +1.19% | +54.14% | +108.47% | 1,043B | |
| -0.87% | -0.00% | +51.36% | +66.78% | 649B | |
| -0.28% | +0.84% | +18.91% | +71.17% | 469B | |
| -0.25% | +0.19% | +36.95% | +45.54% | 355B | |
| +0.98% | +2.91% | +20.59% | +27.14% | 270B | |
| -1.91% | +2.42% | +10.41% | +11.04% | 262B | |
| -0.88% | +8.35% | +42.17% | +52.80% | 222B | |
| -1.43% | +2.04% | +31.73% | +101.39% | 189B | |
| -2.53% | -7.47% | -32.63% | -60.41% | 175B | |
| Average | -1.13% | +2.38% | +24.31% | +53.03% | 363.34B | |
| Weighted average by Cap. | -1.02% | +2.19% | +35.69% | +65.10% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 12.84B 134M 118M 111M 101M 189M 190M 1.33B 515M 6.55B 503M 492M 21.22B | 13.69B 143M 125M 118M 108M 201M 203M 1.42B 549M 6.98B 537M 525M 22.63B |
| Net income | 5.4M 56.37K 49.48K 46.51K 42.52K 79.46K 80.05K 559K 217K 2.75M 212K 207K 8.93M | -74.1M -774K -679K -638K -583K -1.09M -1.1M -7.67M -2.97M -37.78M -2.9M -2.84M -122M |
| Net Debt | 7.92B 82.69M 72.58M 68.23M 62.38M 117M 117M 819M 318M 4.04B 311M 304M 13.09B | 6.79B 70.89M 62.22M 58.49M 53.47M 99.92M 101M 703M 272M 3.46B 266M 260M 11.23B |
Employees
1,669
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-23 | ₹722.90 | -2.91% | 491,844 |
| 26-09-22 | ₹744.55 | -1.15% | 260,825 |
| 26-09-21 | ₹753.25 | +1.51% | 535,832 |
| 26-09-18 | ₹742.05 | +0.05% | 260,108 |
| 26-09-17 | ₹741.70 | +4.24% | 504,562 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SOLARA Stock
Select your edition
All financial news and data tailored to specific country editions
